AcquisitionOther
iSpecimen Inc. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
iSpecimen Inc. -> target · $4.5 million
"These capabilities have the potential to help researchers identify promising protein targets and better understand disease trends.
Open source record (SEC) ↗